Lupus treatment centers on controlling the immune system’s attack on healthy tissue, preventing flares, and protecting organs from long-term damage. There is no cure, but most people with systemic lupus erythematosus (SLE) can reach remission or low disease activity with the right combination of medications and lifestyle adjustments. Treatment is highly individualized because lupus affects everyone differently, from mild joint pain and skin rashes to serious kidney or heart involvement.
Hydroxychloroquine: The Foundation
Nearly every person diagnosed with lupus is started on hydroxychloroquine, an antimalarial drug that has become the backbone of lupus treatment. Current European guidelines recommend it for all patients unless there’s a specific reason they can’t take it. The typical dose is 200 to 400 mg per day, calculated at roughly 5 mg per kilogram of body weight to balance effectiveness against the risk of side effects.
Hydroxychloroquine reduces flares, lowers the risk of organ damage over time, and helps control joint pain, fatigue, and skin symptoms. It also appears to have a protective effect on the kidneys and cardiovascular system. The drug works slowly, sometimes taking weeks or months to reach full effect, so it’s not meant for putting out acute fires. It’s meant to keep them from starting.
The most important long-term concern is eye toxicity. Hydroxychloroquine can, over years, damage the retina. The American Academy of Ophthalmology recommends a baseline eye exam soon after starting the drug, followed by annual screening with imaging tests. If you have no additional risk factors, your doctor may defer annual screening for the first five years, but anyone with risk factors for retinal damage should start yearly exams right away.
Steroids for Flares
When lupus flares, steroids like prednisone are the fastest way to bring inflammation under control. They work within hours to days, making them essential for acute situations. The dose depends on which organs are involved and how severe the flare is. For moderate to severe flares, doctors sometimes use high-dose intravenous pulses of a steroid called methylprednisolone (125 to 1,000 mg per day for one to three days) before switching to oral prednisone.
The goal is always to taper steroids as quickly as safely possible. Guidelines recommend getting down to no more than 5 mg of prednisone per day for maintenance, and ideally stopping altogether. Long-term steroid use causes bone loss, weight gain, elevated blood sugar, cataracts, and increased infection risk. Much of modern lupus treatment strategy revolves around finding other medications that allow you to use less prednisone.
Immunosuppressants as Steroid-Sparing Options
If hydroxychloroquine alone isn’t enough to control symptoms, or if you can’t taper steroids to a safe dose, your doctor will typically add an immunosuppressant. These medications dial down immune system activity more broadly. The choice depends on which symptoms dominate.
- Mycophenolate is used especially for lupus affecting the kidneys, at a typical dose of 2,000 to 3,000 mg per day split into two doses. It’s also one of the first-line treatments for active lupus nephritis.
- Azathioprine helps with joint, skin, liver, and kidney involvement. It’s often used as a maintenance drug after a flare has been controlled and is considered safe enough to continue during pregnancy, which matters for many lupus patients.
- Methotrexate targets joint pain and swelling, particularly when multiple joints are involved. It’s taken once a week, usually 7.5 to 25 mg as a tablet or injection.
All three of these drugs are “steroid-sparing,” meaning they can take over the work of controlling inflammation so your steroid dose can come down. They do suppress the immune system, so you’ll need regular blood work to monitor your liver function, kidney function, and blood cell counts.
Biologic Therapies
Two biologic drugs are currently approved specifically for lupus, and they work in fundamentally different ways.
Belimumab targets a protein that keeps certain immune cells (B cells) alive. By blocking this survival signal, it reduces the number of overactive B cells driving the autoimmune response. It’s given as an injection or infusion and is used for patients whose lupus hasn’t responded well to standard treatment. People with high disease activity and abnormal blood markers (elevated antibody levels, low complement proteins) tend to respond best. Belimumab is also approved for use alongside standard treatments for lupus nephritis.
Anifrolumab takes a different approach. It blocks a receptor for a group of immune signaling molecules called type I interferons, which are overactive in many lupus patients. This receptor exists on nearly every cell in the body, not just immune cells, which may explain the drug’s broad effect on skin rashes, joint symptoms, and fatigue. It’s given as an intravenous infusion every four weeks.
Your doctor may choose one over the other based on your specific symptoms, lab results, and which immune pathways seem most active in your disease.
Treating Lupus Nephritis
Kidney involvement is one of the most serious complications of lupus and requires aggressive treatment. About half of all lupus patients develop some degree of kidney inflammation during their lifetime. Current guidelines recommend treating active lupus nephritis with either mycophenolate or a specific low-dose regimen of cyclophosphamide (a stronger immunosuppressant), combined with steroids.
Newer combination approaches are now recommended as well. A drug called voclosporin, which calms the immune response in the kidneys, can be added to mycophenolate for better results. In clinical trials, patients took voclosporin twice daily alongside mycophenolate and a steroid taper that started at 20 to 25 mg of prednisone per day and dropped to just 2.5 mg by week 16. Belimumab can also be added on top of either mycophenolate or cyclophosphamide for kidney-involved lupus.
Monitoring Whether Treatment Is Working
Lupus treatment isn’t a set-it-and-forget-it situation. During active disease, you’ll typically see your rheumatologist every one to three months for blood work. The key markers doctors track include anti-double-stranded DNA antibodies (which rise when lupus is more active), complement proteins C3 and C4 (which drop during flares because they’re being consumed by the immune response), kidney and liver function tests, complete blood counts, and urine tests to catch early signs of kidney damage.
The treatment target is remission, meaning no signs of active disease while on minimal medication. When full remission isn’t achievable, the next goal is a state of low disease activity. Reaching either of these targets is associated with less organ damage over time.
Sun Protection and Lifestyle Measures
Ultraviolet light is one of the most reliable triggers for lupus flares, particularly skin rashes and joint symptoms. This isn’t optional advice. The Rheumatologic Dermatology Society recommends broad-spectrum sunscreen (blocking both UVA and UVB rays) with SPF 30 or higher every day, even on cloudy days. Mineral sunscreens containing zinc oxide or titanium dioxide are the most effective at blocking both types of UV radiation. Don’t forget SPF 30 lip balm, since lupus-related mouth sores are common.
Beyond sun protection, regular exercise helps manage fatigue and joint stiffness, two of the most persistent lupus symptoms. Adequate sleep matters more than usual because fatigue in lupus isn’t just “being tired.” It’s driven by ongoing immune activation. Smoking significantly worsens lupus outcomes and reduces the effectiveness of hydroxychloroquine, so quitting is one of the highest-impact changes you can make.
How Treatment Evolves Over Time
Lupus treatment is rarely static. You might start with hydroxychloroquine alone during a mild phase, add an immunosuppressant during a flare, layer on a biologic if standard drugs aren’t enough, and eventually taper back down during periods of remission. The overall trajectory for most patients has improved substantially. With current treatment options, the majority of people with lupus can expect to reach low disease activity and avoid the kind of severe organ damage that was common decades ago.
The drugs used depend on which organs are affected, how severe the disease is, whether you’re planning a pregnancy, and how you respond to initial treatment. What works for one person may not work for another, which is why lupus care typically involves close, ongoing collaboration with a rheumatologist who can adjust the plan as your disease changes.